Moderna therapeutics, INC:advance the development of an mrna vaccine for the prevention of zika virus

Ended Definitive Contract Awarded Last action

Contract number
HHSO100201600029C
Awardee
Awarding agency
Obligated
$72,965,186

Award facts

Opportunity
  • BAA16100SOL0001 Solicitation number
Contract value 90% obligated
  • $72,965,185.67 Current, with exercised options
  • $81,397,873.67 Potential, with all options
Completion date 100% complete
Current and potential, with all options
Contracting staff
Set-aside
No set-aside
Competition
Full and Open Competition · 1 offer Negotiated Proposal / Quote
Pricing
Cost Plus Fixed Fee
Place of performance
Cambridge, MA 02139, USA
Legislative mandates

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Other Administrative Action P00012 · The purpose of this modification is to deobligate funding in the amount of $6,336.92 in cancelling funds from clin 0001. -$6,337
Other Administrative Action P00011 · This no cost modification is to change the period of performance from 09/01/2016 to 07/01/2024. The current NCE is for an additional 6 months from the… $0
Other Administrative Action P00010 · This no cost modification is to change the contracting officer from jonathan gonzalez to erin greninger. Accordingly, under section G.1. Contracting officer,… $0
Other Administrative Action P00009 · This modification is to DE-obligate the amount of $36,249,104.41 of funding which will otherwise expire -$36,249,104
Other Administrative Action P00008 · To change POP end and add new SOW $0
Other Administrative Action P00007 -$8,097,343
Other Administrative Action P00006 $0
Supplemental Agreement for work within scope 5 $0
Supplemental Agreement for work within scope 4 $0
Exercise an Option 3 $0
Exercise an Option 2 $64,906,443
Exercise an Option 1 $44,205,768
Original award $8,205,759
Show all 13

About this award

Written by GovTribe AI ·

This is a definitive contract awarded by the Office of the Assistant Secretary for Preparedness and Response (ASPR), a civilian agency within the Department of Health and Human Services (HHS), to Modernatx, Inc. The $81,397,873.67 cost-plus-fixed-fee contract is to advance the development of a messenger RNA (mRNA) vaccine for the prevention of Zika virus. The contract has a completion date of July 1, 2024. Modernatx, Inc. is a for-profit manufacturer of pharmaceutical goods that has provided COVID-19 mRNA vaccines, accelerated RNA technology, mRNA-encoded antibodies against SARS-CoV-2, and scaled up domestic manufacturing capacity of mRNA vaccines under previous prime and subcontract awards with government agencies including the Department of Veterans Affairs, Defense Advanced Research Projects Agency, Department of the Army, and HHS. No set-aside designation was used for this award.

Quick answers

Who was awarded contract HHSO100201600029C?

HHSO100201600029C was awarded to Modernatx, Inc. by Office of the Assistant Secretary for Preparedness and Response (Department of Health and Human Services) on September 1, 2016.

How much is contract HHSO100201600029C worth?

The government has obligated $72,965,186 on HHSO100201600029C. Its potential value, with all options, is $81,397,874.

Was contract HHSO100201600029C competed?

The extent of competition for HHSO100201600029C was full and open competition. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award
Try for free Login